Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.57 |
| ▸ | BACE1 | P56817 | 7/20 | 0.55 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | FNTA | P49354 | 3/20 | 0.53 |
| ▸ | FNTB | P49356 | 3/20 | 0.53 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.53 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9597700 | 0.97 | LTA4H (0.56) | NAALAD2BACE1LTA4HFNTAFNTB | |
| SCHEMBL9597693 | 0.97 | LTA4H (0.56) | NAALAD2BACE1LTA4HFNTAFNTB | |
| SCHEMBL29630374 | 0.95 | BACE1 (0.62) | BACE1BACE2 | |
| SCHEMBL30050929 | 0.93 | FNTA (0.59) | LTA4HFNTAFNTBPGGT1B | |
| SCHEMBL29378966 | 0.92 | FNTA (0.58) | LTA4HFNTAFNTBPGGT1B | |
| SCHEMBL10696437 | 0.92 | FNTA (0.60) | LTA4HFNTAFNTBPGGT1B | |
| SCHEMBL13154780 | 0.92 | FNTA (0.60) | LTA4HFNTAFNTBPGGT1B | |
| SCHEMBL9442973 | 0.92 | FNTA (0.60) | LTA4HFNTAFNTBPGGT1B | |
| SCHEMBL9442969 | 0.92 | FNTA (0.60) | LTA4HFNTAFNTBPGGT1B | |
| SCHEMBL6241495 | 0.91 | LTA4H (0.60) | NAALAD2BACE1LTA4HFNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |